Rich Pharmaceuticals Inc. (fka RCHA)

[MaxYazger]

RCHA IMPORTANT EVENTS CALENDAR........

Jan4 2016
Litigation has been settled through a confidential mediation process supervised by the Federal Court and the Litigation is now in the process of being dismissed with prejudice by the Federal Court.
http://biz.yahoo.com/e/160104/rcha8-k.html

Dec 28, 2015
Rich Pharmaceuticals, Inc. Receives FDA Approval for a Phase 1/2 Study in AML & MDS
http://www.marketwatch.com/story/rich-pharmaceuticals-inc-receives-fda-approval-for-a-phase-12-study-in-aml-mds-2015-12-28?siteid=bigcharts&dist=bigcharts

Nov 23, 2015
Rich Pharmaceuticals Announces Additional Submission To The U.S. Food and Drug Administration (FDA
http://www.marketwatch.com/story/rich-pharmaceuticals-announces-additional-submission-to-the-us-food-and-drug-administration-fda-2015-11-23?siteid=bigcharts&dist=bigcharts

Oct 7 , 2015
Rich Pharmaceuticals Retains Theradex Systems To Finalize Investigational New Drug Application And Initiate Next Phases Of Clinical Trials
http://finance.yahoo.com/news/rich-pharmaceuticals-retains-theradex-systems-131500181.html

Aug 11, 2015
Rich Pharmaceuticals, Inc. Appoints Richard Salvador, Ph.D., Research & Development Expert, To Board of Directors
http://www.marketwatch.com/story/rich-pharmaceuticals-inc-appoints-richard-salvador-phd-research-development-expert-to-board-of-directors-2015-08-11-11183330?siteid=bigcharts&dist=bigcharts

Mar 24, 2015
Rich Pharmaceuticals, Inc. Announces Letter of Intent with Faculty of Medicine at Khon Kaen University to Conduct Acute Myelocytic Leukemia Clinical Trials PR Newswire - PRF
http://www.marketwatch.com/story/rich-pharmaceuticals-inc-announces-letter-of-intent-with-faculty-of-medicine-at-khon-kaen-university-to-conduct-acute-myelocytic-leukemia-clinical-trials-2015-03-24?siteid=bigcharts&dist=bigcharts

Mar 12, 2015
Rich Pharmaceuticals, Inc. Names Chittima Sirijerachai, MD as Principal Investigator for Upcoming AML Clinical Trials
http://www.marketwatch.com/story/rich-pharmaceuticals-inc-names-chittima-sirijerachai-md-as-principal-investigator-for-upcoming-aml-clinical-trials-2015-03-12?siteid=bigcharts&dist=bigcharts

Feb 23, 2015
Rich Pharmaceuticals, Inc. Highlights 2014 Significant Accomplishments
http://www.marketwatch.com/story/rich-pharmaceuticals-inc-highlights-2014-significant-accomplishments-2015-02-23?siteid=bigcharts&dist=bigcharts

Feb 04, 2015
Rich Pharmaceuticals Announces Completion of the Manufacture of RP-323 Study Drug in Connection with Obtaining FDA's Final Approval of The Investigational New Drug (IND) Application For The Treatment of Acute Myelocytic Leukemia PR Newswire - PRF
http://www.marketwatch.com/story/rich-pharmaceuticals-announces-completion-of-the-manufacture-of-rp-323-study-drug-in-connection-with-obtaining-fdas-final-approval-of-the-investigational-new-drug-ind-application-for-the-treatment-of-acute-myelocytic-leukemia-2015-02-04?siteid=bigcharts&dist=bigcharts